DELvision: Improving Data-Driven Drug Discovery
DELvision is a powerful DNA encoded library (DEL)-based toolset for AIphaFold-assisted drug discovery and target sciences.
In contrast to conventional screens where the target space is low-dimensional, DELvision comprises a high-dimensional map of binding relationships between small molecules and protein targets. As such, this rich data universe enables simultaneous characterization of targets and exploration of the target-modulating chemical space
DELvision offers high quality, off-the-shelf DEL screening data covering thousands of targets. In addition, DELvision is positioned to provide valuable training data for machine learning of structure-activity relationships.
Related Content
Peptide-based therapeutics have emerged as a significant class of drugs in the pharmaceutical landscape, offering numerous advantages, including high specificity,...
VIEW RESOURCEHit validation is a crucial step in drug discovery based on DNA-encoded libraries (DEL). Rapid and accurate resynthesis of compounds,...
VIEW RESOURCE